Abstract:Evidence in animal models suggests IL-1 family cytokines interact with central endogenous opioid neurotransmitter systems, inducing or perpetuating pathological states such as persistent pain syndromes, depression, substance use disorders, and their comorbidity. Understanding these interactions in humans is particularly relevant to understanding pathological states wherein this neurotransmitter system is implicated (ie, persistent pain, mood disorders, substance use disorders, etc). Here, we examined relationships between IL-1β, IL-1ra, and functional measures of the endogenous opioid system in 34 healthy volunteers, in the absence and presence of a standardized sustained muscular pain challenge, a psychophysical challenge with emotionally and physically stressful components. Mu-opioid receptor availability in vivo was examined with [11C]carfentanil positron emission tomography (PET) scanning. Sex and neuroticism impacted IL-1 family cytokines; higher baseline IL-1β and IL-1ra was identified in females with lower neuroticism. Higher baseline IL-1β was also associated with reduced μ-opioid receptor availability (amygdala) and greater pain sensitivity. The pain challenge increased IL-1β in females with high neuroticism. Strong associations between IL-1ra (an anti-nociceptive cytokine) and μ-opioid receptor activation (VP/NAcc) were identified during the pain challenge and the resulting analgesic effect of μ-opioid receptor activation was moderated by changes in IL-1β whereby volunteers with greater pain induced increase in IL-1β experienced less endogenous opioid analgesia. This study demonstrates the presence of relationships between inflammatory factors and a specific central neurotransmitter system and circuitry, of relevance to understanding interindividual variations in regulation of responses to pain and other physical and emotional stressors.

Interleukin-2: Structural and Biological Relatedness to Opioid Peptides

Opioid Receptor-Mediated Effects of Interleukin-2 on the [ca2+]i Transient and Contraction in Isolated Ventricular Myocytes of the Rat

Effect of Interleukin-2 on Intracellular Calcium Transients in Rat Ventricular Myocytes

Interleukin-2-induced Antinociception in Morphine-Insensitive Rats.

Distinct structural bases of the immunoregulatory and central analgesic effects of IFNalpha

Interleukin-2 regulates membrane potentials and calcium channels via μ opioid receptors in rat dorsal root ganglion neurons

Distinct structural bases of the immunoregulatory and central analgesic effects of IFNα

Structural Basis for Bifunctional Peptide Recognition at Human Δ-Opioid Receptor

The Analgesic Domain of Interferon-α2b Contains an Essential Proline39 Residue

Fever of Recombinant Human Interferon-Alpha is Mediated by Opioid Domain Interaction with Opioid Receptor Inducing Prostaglandin E2

Distinct Domains of IFNalpha Mediate Immune and Analgesic Effects Respectively.

The Analgesic Domain of Interferon-Alpha 2b Contains an Essential Proline(39) Residue

Dynamic Interactions Between Plasma IL-1 Family Cytokines and Central Endogenous Opioid Neurotransmitter Function in Humans

Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally.

Involvement of Interleukin-2 in Analgesia Produced by Coriolus Versicolor Polysaccharide Peptides.

Interleukin-17 Regulates Neuron-Glial Communications, Synaptic Transmission, and Neuropathic Pain after Chemotherapy.

Experimental Study: Interleukin-31 Augments Morphine-Induced Antinociceptive Activity and Suppress Tolerance Development in Mice

Interleukin-17 regulates neuron-glial communications, inhibitory synaptic transmission and neuropathic pain after chemotherapy

A Study of Interleukin-2 in PBMC of Chronic Opioid Addicts by the Immunohistochemistry

Inhibition of nociceptive withdrawal reflex by microinjection of interleukin 2 into rat locus coeruleus

Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist